Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10914916 | Molecular Oncology | 2012 | 5 Pages |
Abstract
A common side effect of cancer treatment is bone marrow suppression. The resulting myelosuppression and anemia can cause significant morbidity and mortality for patients. Agents such as granulocyte colony stimulating factors (GCSF) and erythropoietin stimulating agents (ESAs) may be helpful to ameliorate this depression of blood counts; however these agents have risks which also need to be carefully weighed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shannon Puhalla, Saveri Bhattacharya, Nancy E. Davidson,